Research programme: monoclonal antibodies - Human Genome Sciences/KAN Research Institute/Morphotek
Alternative Names: Humanised monoclonal antibodies (mAbs) - Human Genome Sciences/EisaiLatest Information Update: 04 Nov 2017
Price :
$50 *
At a glance
- Originator Human Genome Sciences; KAN Research Institute; Morphotek
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer; Dermatitis; Immunological disorders; Rheumatoid arthritis
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in USA (Parenteral)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Dermatitis in USA (Parenteral)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Immunological-disorders in USA (Parenteral)